As of June 21, 2025, Poniard Pharmaceuticals Inc (PARD) reports a Graham Number of N/A.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Comparing Poniard Pharmaceuticals Inc's Graham Number to Peers
To better understand Poniard Pharmaceuticals Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Poniard Pharmaceuticals Inc (PARD) | - |
| Karuna Therapeutics Inc (KRTX) | 42.65 |
| Atreca Inc (BCEL) | 16.00 |
| Caladrius Biosciences Inc (CLBS) | 3.95 |
| TetraLogic Pharmaceuticals Corp (TLOG) | 3.29 |
Compared to its competitors, Poniard Pharmaceuticals Inc's Graham Number is difficult to compare due to insufficient data.